Literature DB >> 12214285

A rare haplotype of the RET proto-oncogene is a risk-modifying allele in hirschsprung disease.

Paola Griseri1, Barbara Pesce, Giovanna Patrone, Jan Osinga, Francesca Puppo, Monica Sancandi, Robert Hofstra, Giovanni Romeo, Roberto Ravazzolo, Marcella Devoto, Isabella Ceccherini.   

Abstract

Hirschsprung disease (HSCR) is a common genetic disorder characterized by intestinal obstruction secondary to enteric aganglionosis. HSCR demonstrates a complex pattern of inheritance, with the RET proto-oncogene acting as a major gene and with several additional susceptibility loci related to the Ret-signaling pathway or to other developmental programs of neural crest cells. To test how the HSCR phenotype may be affected by the presence of genetic variants, we investigated the role of a single-nucleotide polymorphism (SNP), 2508C-->T (S836S), in exon 14 of the RET gene, characterized by low frequency among patients with HSCR and overrepresentation in individuals affected by sporadic medullary thyroid carcinoma. Typing of several different markers across the RET gene demonstrated that a whole conserved haplotype displayed anomalous distribution and nonrandom segregation in families with HSCR. We provide genetic evidence about a protective role of this low-penetrant haplotype in the pathogenesis of HSCR and demonstrate a possible functional effect linked to RET messenger RNA expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12214285      PMCID: PMC378552          DOI: 10.1086/342774

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Segregation at three loci explains familial and population risk in Hirschsprung disease.

Authors:  Stacey B Gabriel; Rémi Salomon; Anna Pelet; Misha Angrist; Jeanne Amiel; Myriam Fornage; Tania Attié-Bitach; Jane M Olson; Robert Hofstra; Charles Buys; Julie Steffann; Arnold Munnich; Stanislas Lyonnet; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2002-04-15       Impact factor: 38.330

2.  A genetic study of Hirschsprung disease.

Authors:  J A Badner; W K Sieber; K L Garver; A Chakravarti
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

Review 3.  Genetics of Hirschsprung disease.

Authors:  M A Parisi; R P Kapur
Journal:  Curr Opin Pediatr       Date:  2000-12       Impact factor: 2.856

4.  Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET.

Authors:  S M Myers; C Eng; B A Ponder; L M Mulligan
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

5.  Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis.

Authors:  E de Graaff; S Srinivas; C Kilkenny; V D'Agati; B S Mankoo; F Costantini; V Pachnis
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

6.  Expression of RET 3' splicing variants during human kidney development.

Authors:  S M Ivanchuk; S M Myers; L M Mulligan
Journal:  Oncogene       Date:  1998-02-26       Impact factor: 9.867

7.  DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene.

Authors:  I Ceccherini; R M Hofstra; Y Luo; R P Stulp; V Barone; T Stelwagen; R Bocciardi; H Nijveen; A Bolino; M Seri
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

8.  Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.

Authors:  T Attié; A Pelet; P Edery; C Eng; L M Mulligan; J Amiel; L Boutrand; C Beldjord; C Nihoul-Fékété; A Munnich
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

9.  A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease.

Authors:  E G Puffenberger; K Hosoda; S S Washington; K Nakao; D deWit; M Yanagisawa; A Chakravart
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

10.  Cell-line specific chromatin acetylation at the Sox10-Pax3 enhancer site modulates the RET proto-oncogene expression.

Authors:  Francesca Puppo; Paola Griseri; Mirco Fanelli; Francesca Schena; Giovanni Romeo; PierGiuseppe Pelicci; Isabella Ceccherini; Roberto Ravazzolo; Giovanna Patrone
Journal:  FEBS Lett       Date:  2002-07-17       Impact factor: 4.124

View more
  9 in total

1.  A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.

Authors:  Salud Borrego; Fred A Wright; Raquel M Fernández; Nita Williams; Manuel López-Alonso; Ramana Davuluri; Guillermo Antiñolo; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

2.  Clinical relationship between EDN-3 gene, EDNRB gene and Hirschsprung's disease.

Authors:  Xiang-Long Duan; Xian-Sheng Zhang; Guo-Wei Li
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

3.  RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.

Authors:  V Neocleous; N Skordis; G Portides; E Efstathiou; C Costi; N Ioannou; M Pantzaris; V Anastasiadou; C Deltas; L A Phylactou
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

Review 4.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

5.  Polymerase chain reaction-single strand conformational polymorphism analysis of rearranged during transfection proto-oncogene in Chinese familial Hirschsprung's disease.

Authors:  Tao Guan; Ji-Cheng Li; Min-Ju Li; Jin-Fa Tou
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

6.  Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients.

Authors:  Surasak Sangkhathat; Takeshi Kusafuka; Piyawan Chengkriwate; Sakda Patrapinyokul; Burapat Sangthong; Masahiro Fukuzawa
Journal:  J Hum Genet       Date:  2006-09-29       Impact factor: 3.172

Review 7.  Multiple endocrine neoplasias type 2B and RET proto-oncogene.

Authors:  Giuseppe Martucciello; Margherita Lerone; Lara Bricco; Gian Paolo Tonini; Laura Lombardi; Carmine G Del Rossi; Sergio Bernasconi
Journal:  Ital J Pediatr       Date:  2012-03-19       Impact factor: 2.638

8.  Rescue of human RET gene expression by sodium butyrate: a novel powerful tool for molecular studies in Hirschsprung disease.

Authors:  P Griseri; G Patrone; F Puppo; G Romeo; R Ravazzolo; I Ceccherini
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

9.  Effect of 3'UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma.

Authors:  Lucieli Ceolin; Mirian Romitti; Débora Rodrigues Siqueira; Carla Vaz Ferreira; Jessica Oliboni Scapineli; Beatriz Assis-Brazil; Rodolfo Vieira Maximiano; Tauanne Dias Amarante; Miriam Celi de Souza Nunes; Gerald Weber; Ana Luiza Maia
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.